Vir Biotechnology

+$2.66 (+6.73%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VIR and other stocks, options, and ETFs commission-free!

About VIR

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.

CEO
George A. Scangos
Employees
327
Headquarters
San Francisco, California
Founded
2016

VIR Key Statistics

Market Cap
5.52B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
614.54K
High Today
$42.88
Low Today
$39.93
Open Price
$39.93
Volume
556.10K
52 Week High
$141.01
52 Week Low
$25.31

VIR Earnings

-$4.60
-$3.07
-$1.53
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.21 per share
Actual
-$1.32 per share

You May Also Like

NDACU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure